Italia markets open in 7 hours 11 minutes

ILMN Jan 2025 210.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,60000,0000 (0,00%)
In data: 10:50AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente3,6000
Aperto3,6000
Denaro0,7500
Lettera3,0000
Prezzo d'esercizio210,00
Scadenza2025-01-17
Min-Max giorno3,6000 - 3,6000
Contratto - Min-MaxN/D
Volume2
Open Interest145
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera